This feedback is anonymous. Please Contact us if you would like a response.

World Anti-Doping Agency and Partnership for Clean Competition funded anabolic steroids

Main content area

The National Measurement Institute (NMI) produce reference materials (RMs) in accordance with our accreditation from NATA to ISO 17034:2016(E) General requirements for the competence of reference materials producers. We supply RMs with product information sheets and safety data sheets.

Displaying 1 - 45 of 45
Category Description NMI Reference Unit of issue Domestic Cost (A$ excl GST) International cost (A$) Certificate
WADA PCCSteroids and steroid metabolite1-Androstendione

1-Androstendione (5α-Androst-1-en-3,17-dione) *

D845 1 207 290 PDF icon D845
WADA PCCSteroids and steroid metaboliteDanazol metabolites

2a-Hydroxymethylethisterone  

D920b 1 110 154 PDF icon D920b
WADA PCCSteroids and steroid metaboliteNandrolone metabolites

19-Noretiocholanolone sulfate (Na salt)*

D849 1 110 154 PDF icon D849
WADA PCCSteroids and steroid metabolite

Epinandrolone sulfate† TEA salt

D783b 1 110 154 PDF icon D783b
WADA PCCSteroids and steroid metaboliteFinasteride metabolites

Carboxy finasteride 

S045 1 110 154 PDF icon S045
WADA PCCSteroids and steroid metabolite4-Hydroxy steroids

4-Hydroxy-estr-4-en-3,17-dione   

S043 1 (ampoule) 110 154 PDF icon S043
WADA PCCSteroids and steroid metabolite17a-Methylclostebol metabolite

4-Chloro-17a-methyl-androst-4-ene-3a, 17b-diol 

S044 1 (ampoule) 110 154 PDF icon S044
WADA PCCSteroids and steroid metaboliteMethyldienolone

Methyldienolone

D916b 1 (ampoule) 110 154 PDF icon D916b
WADA PCCSteroids and steroid metaboliteNorbolethone and metabolites

13b,17a-Diethyl-5b-gonane-3a, 17b-diol

(major metabolite)

D818b 1 (ampoule) 110 154 PDF icon D818b
WADA PCCSteroids and steroid metaboliteNorbolethone and metabolites

Norbolethone

(13b,17a-diethyl-gonan-4-ene-17b-ol-3-one) 

D825c 1 (ampoule) 110 110 PDF icon D825c
WADA PCCSteroids and steroid metaboliteNorbolethone and metabolites

13b,17a-Diethyl-5a-gonane-3a, 17b-diol

(minor metabolite)

D820b 1 (ampoule) 110 154 PDF icon D820b
WADA PCCSteroids and steroid metaboliteOral Turinabol metabolite

6b-Hydroxy-oral turinabol

D615b 1 (ampoule) 110 154 PDF icon D615b
WADA PCCSteroids and steroid metaboliteTestosterone metabolites (including internal standards)

D4-5a-Androstan-3a,17b-diol-3-O-b-glucuronic acid*

S010 1 110 154 PDF icon S010
WADA PCCSteroids and steroid metaboliteTestosterone metabolites (including internal standards)

D5-5b-Androstan-3a,17b-diol-3-O-b-glucuronic acid*

S012 1 110 154 PDF icon S012
WADA PCCSteroids and steroid metaboliteTestosterone metabolites (including internal standards)

D5-Etiocholanolone-3-O-b-glucuronide sodium salt*

S020 1 110 154 PDF icon S020
WADA PCCSteroids and steroid metaboliteTestosterone metabolites (including internal standards)

D4-5a-Androstan-3a,17b-diol-17-O-b-glucuronic acid*

S009 1 110 154 PDF icon S009
WADA PCCSteroids and steroid metaboliteTestosterone metabolites (including internal standards)

D3-5b-Androstan-3a,17b-diol-17-O-b-glucuronic acid*

S011 1 110 154 PDF icon S011
WADA PCCSteroids and steroid metaboliteTestosterone metabolites (including internal standards)

D4-Epitestosterone-17-O-b-glucuronic acid*

S023 1 110 154 PDF icon S023
WADA PCCSteroids and steroid metaboliteTestosterone metabolites (including internal standards)

5b-Androstane-3a,17b-diol-3-b-glucuronic acid

S003b 1 110 154 PDF icon S003b
WADA PCCSteroids and steroid metabolite1-Testosterone*

5α-Androst-1-ene-3a-ol-17-one* (Ampouled)

D832 0.2 110 154 PDF icon D832
WADA PCCSteroids and steroid metaboliteProhormones and metabolites

4b-Hydroxy DHEA*

D834 1 (ampoule) 110 154 PDF icon D834
WADA PCCSteroids and steroid metaboliteProhormones and metabolites

7a-Hydroxy DHEA*

D875 1 110 154 PDF icon D875
WADA PCCSteroids and steroid metaboliteProhormones and metabolites

16b-Hydroxy DHEA*

D844 1 110 154 PDF icon D844
WADA PCCSteroids and steroid metaboliteProhormones and metabolites

3a,5-Cyclo-5a-androstan-6b-ol-17-one

S039 1 (ampoule) 110 154 PDF icon S039
WADA PCCSteroids and steroid metaboliteProhormones and metabolites

3b-Hydroxy-4-estren-17-one*

D866 1 110 154 PDF icon D866
WADA PCCSteroids and steroid metaboliteProhormones and metabolites

6b-Hydroxyetiocholanolone*

D867 1 110 154 PDF icon D867
WADA PCCSteroids and steroid metaboliteProhormones and metabolites

7-Keto DHEA*

D833 10 110 154 PDF icon D833
WADA PCCSteroids and steroid metaboliteProhormones and metabolites

7b-Hydroxy DHEA*

D865 1 110 154 PDF icon D865
WADA PCCSteroids and steroid metaboliteProhormones and metabolites

3a-Hydroxy-4-estren-17-one*

D873 1 110 154 PDF icon D873
WADA PCCSteroids and steroid metaboliteProhormones and metabolites

16α-Hydroxyandrosterone*

D843 1 (ampoule) 110 154 PDF icon D843
WADA PCCSteroids and steroid metaboliteREV-ERB agonist SR9009 metabolites

N-[(4-Chlorophenyl)methyl]-5-nitro-2-thiophenemethanamine hydrochloride 

D1066 1 (ampoule) 110 154 PDF icon D1066
WADA PCCSteroids and steroid metaboliteREV-ERB agonist SR9009 metabolites

Ethyl N-(5-nitro-2-methylthiophene)-3-aminomethylpyrrolidine-1-carboxylate 

D1067 1 (ampoule) 110 154 PDF icon D1067
WADA PCCSteroids and steroid metaboliteStimulants

Formoterol fumarate

D1065 25 110 154 PDF icon D1065
WADA PCCSteroids and steroid metaboliteStimulants

Higenamine hydrochloride 

D1070 25 110 154 PDF icon D1070
WADA PCCSteroids and steroid metabolitesSteroid carbon isotope ratio standard mixture reference material for GCC-IRMS

Carbon isotope delta value reported for 5a-androstan-3a-ol-17-one acetate (d13CVPDB / ‰ -32.73 ± 0.06), 5b-androstan-3a, 17b-diacetate (d13CVPDB / ‰ -30.19 ± 0.07), 5a-cholestane (d13CVPDB / ‰ -24.83 ± 0.13), and 5b- pregnan-3a, 20a-diacetate (d13CVPDB / ‰ -21.16 ± 0.08)

CU-PCC 44-1 Ampoule 110 154 PDF icon CU-PCC 44-1
WADA PCCSteroids and steroid metabolitesSteroid carbon isotope ratio standard mixture reference material for GCC-IRMS

Carbon isotope delta value reported for 5a-androstan-3b-ol acetate (d13CVPDB / ‰ -32.00 ± 0.09), 5a-androstan-3a-ol-17-one acetate (d13CVPDB / ‰ -32.58 ± 0.03), 5b-androstan-3a-ol-11,17-dione acetate (d13CVPDB / ‰ -16.50 ± 0.03), and 5a-cholestane (d13CVPDB / ‰ -24.90 ± 0.05)

CU-PCC 33-2 Ampoule 110 154 PDF icon CU-PCC 33-2
WADA PCCSteroids and steroid metabolitesSteroid carbon isotope ratio standard mixture reference material for GCC-IRMS

Carbon isotope delta value reported for 5a-androstan-3a-ol-17-one (d13CVPDB / ‰ -27.09 ± 0.07)

CU-PCC 40-1 Ampoule 110 154 PDF icon CU-PCC 40-1
WADA PCCSteroids and steroid metabolitesSteroid carbon isotope ratio standard mixture reference material for GCC-IRMS

Carbon isotope delta value reported for 5a-cholestane (d13CVPDB / ‰ -25.03 ± 0.01)

CU-PCC 42-1 Ampoule 110 154 PDF icon CU-PCC 42-1
WADA PCCSteroids and steroid metabolitesSteroid carbon isotope ratio standard mixture reference material for GCC-IRMS

Carbon isotope delta value reported for 5b-androstan-3a-ol-17-one (d13CVPDB / ‰ -28.75 ± 0.01), 5a-androstan-3a-ol-17-one (d13CVPDB / ‰ -26.74 ± 0.03), 5b-pregnan-3a, 20a-diol (d13CVPDB / ‰ -18.65 ± 0.03)

CU-PCC 34-3 Ampoule 110 154 PDF icon CU-PCC 34-3
WADA PCCSteroids and steroid metabolitesSteroid carbon isotope ratio standard mixture reference material for GCC-IRMS

Carbon isotope delta value reported for 5a-androstan-3a-ol-17-one acetate (d13CVPDB / ‰ -32.82 ± 0.02)

CU-PCC 41-1 Ampoule 110 154 PDF icon CU-PCC 41-1
WADA PCCSteroids and steroid metabolitesSteroid Matrix Reference Material

Carbon Isotope Delta Value of 19-norandrosterone

in Water containing 20% Methanol 1 (mL) *

d13CVPDB / ‰ –29.7 ± 0.8

MX016 Ampoule 220 308 PDF icon MX016
WADA PCCSteroids and steroid metabolitesSteroid Matrix Reference Material

Carbon Isotope Delta Value (d13CVPDB / ‰).  Three ampoules containing dry steroid mixtures. The ampoules contain approximately 400 µg of each steroid with the exception of 16-androstenol supplied close to 280 µg.
Vial 1:  etiocholanolone (-27.94 ± 0.24), androsterone (-27.79 ± 0.21),
11-oxoetiocholanolone (-13.58 ± 0.23), testosterone (-27.87 ± 0.24),
11β-hydroxyetiocholanolone -29.51 ± 0.36)
Vial 2: 5β-androstane-3α-17β-diol (-29.86 ± 0.16), 5α androstane-3α-17β-diol (-31.14 ± 0.24), pregnanediol (-16.79 ± 0.42),
epitestosterone (-30.17 ± 0.36),
11β-hydroxyandrosterone (-28.59 ± 0.22)
Vial 3: 16-androstenol (-30.96 ± 0.37), dehydroepiandrosterone (-31.63 ± 0.54), testosterone (-22.52 ± 0.33)

MX018 3 Ampoules 240 336 PDF icon MX018
WADA PCCSteroids and steroid metabolitesSteroid Matrix Reference Material

19-Norandrosterone (221.4 ng/g) in

1,2-dimethoxyethane (1 mL) *

MX003 Ampoule 165 242 PDF icon MX003
WADA PCCSteroids and steroid metabolitesSteroid Matrix Reference Material

Mass fraction of testosterone metabolites in freeze dried human urine: 5α-androstane-3α-17β-diol (41.2 ± 1.8 ng/g), 5β‑androstane-3α-17β-diol (66.0 ± 2.9 ng/g), androsterone 1652 ± 29 ng/g), etiocholanolone (1359 ± 36 ng/g), testosterone (88.1 ± 4.2 ng/g), epitestosterone (21.9 ± 1.0 ng/g), T/E mass ratio (4.03 ± 0.26) *

MX017 Bottle 240 336 PDF icon MX017
WADA PCCSteroids and steroid metaboliteAnti-inflammatory metabolites

a-Hydroxycarprofen 

D1072 5 110 154 PDF icon D1072